Cullinan Therapeutics, Inc. (CGEM) Insider Trading Disclosures
Cullinan Therapeutics, Inc. (CGEM) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CGEM
CIK: 1789972
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerJennifer Plotnick
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-02 | 2026-10-01 | 8-K | 0001193125-26-411011 | View SEC Doc Filr Page |
| 8-K | 2026-09-24 | 2026-09-24 | 8-K | 0001193125-26-400144 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-13 | 8-K | 0001193125-26-389844 | View SEC Doc Filr Page |
| 4 | 2026-09-10 | 2026-09-08 | 4 | 0001193125-26-387381 | View SEC Doc Filr Page |
| 144 | 2026-09-08 | — | 144 Filing | 0001950047-26-009190 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-13 | 4 | 0001193125-26-352523 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000921895-26-002166 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0000080255-26-000574 | View SEC Doc Filr Page |
| 144 | 2026-08-13 | — | 144 Filing | 0001950047-26-008087 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-12 | 8-K | 0001193125-26-347400 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0000093751-26-000446 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001193125-26-336717 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001193125-26-336700 | View SEC Doc Filr Page |
| 4 | 2026-07-07 | 2026-07-06 | 4 | 0001193125-26-297605 | View SEC Doc Filr Page |
| 144 | 2026-07-06 | — | 144 Filing | 0001950047-26-006865 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | 4 | 0001193125-26-294869 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | 4 | 0001193125-26-294863 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 | 0001193125-26-276060 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 | 0001193125-26-276059 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 | 0001193125-26-276057 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 | 0001193125-26-276056 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 | 0001193125-26-276055 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 | 0001193125-26-276054 | View SEC Doc Filr Page |
| 8-K | 2026-06-16 | 2026-06-16 | 8-K | 0001193125-26-272890 | View SEC Doc Filr Page |
| 8-K | 2026-06-10 | 2026-06-10 | 8-K | 0001193125-26-264916 | View SEC Doc Filr Page |